A recent study uncovers how drug-resistant cancer cells induce changes in the tumor microenvironment. This phenomenon promotes cancer recurrence and explains why initially effective targeted therapies can lose their efficacy over time. The research is published in the journal Nature Communications.
Go to Source
Author: